Navigation Links
No Proof That 'Doping' With EPO Gives Athletes an Edge: Review
Date:12/7/2012

FRIDAY, Dec. 7 (HealthDay News) -- Erythropoietin, more commonly known as EPO, has been banned from sports due to a belief that it provides an unfair competitive advantage to users, but new research found there is no scientific evidence the blood-cell stimulating hormone actually enhances athletes' performance.

EPO has been in the news recently because of its reported use by the American cyclist Lance Armstrong, who won the Tour de France a record-breaking seven times. He was stripped of those titles in October.

While the scientists who conducted a systemic review of existing studies on EPO did not find proof of performance-enhancing benefits, they did find that possible harm from use of the hormone was well-documented.

In their report, published in the Dec. 6 issue of the British Journal of Clinical Pharmacology, they warned that EPO doping thickens the blood and could increase a person's risk for clots, which could result in heart attack or stroke.

"Athletes and their medical staff may believe EPO enhances performance, but there is no evidence that anyone performed good experiments to check if EPO would actually improve performance in elite cyclists," lead researcher Dr. Adam Cohen, of the Centre for Human Drug Research in Leiden, the Netherlands, said in a journal news release.

EPO is a drug used to treat anemia. Patients treated with EPO are carefully monitored due to the drug's potentially serious side effects.

"So why should the standards be different for the same drugs used in athletes?" noted Cohen. "Although doping is forbidden, the pressure to win in sport is so great that some athletes seem to be willing to try any way of getting ahead of their competitors. When elite athletes and their coaches discover that there is no evidence of benefit and clear risk of harm, I hope many may reconsider trying to cheat. Education may work where attempts at enforcement have failed," he said in the news release.

The researchers concluded more research is needed to explore the effects of so-called performance enhancing drugs to improve safety among athletes.

"If, as is expected, many substances in current use are found to be ineffective it will help keep our athletes safe and improve confidence in sporting results," Cohen said.

More information

The World Anti-Doping Agency has more about EPO.

-- Mary Elizabeth Dallas

SOURCE: British Journal of Clinical Pharmacology, news release, Dec. 6, 2012


'/>"/>
Copyright©2012 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. No Proof That Gum Disease Causes Heart Disease, Experts Say
2. More Proof That Healthy Habits Fight Disease
3. More Proof Cranberry Juice Thwarts Infection
4. No proof that patients lose weight after joint replacement surgery
5. Vandetanib in thyroid cancer: No proof of added benefit
6. Could Gene Doping Be Part of Future Olympics?
7. London Olympics anti-doping labs set for first-of-a-kind repurposing
8. U.S. Gives Green Light to Publish Controversial Bird Flu Research
9. Image share project gives patients and physicians anytime, anywhere access to medical images
10. Procedure gives patients with A-fib who cant take blood thinners alternative to reduce stroke
11. UMD team gives drug dropouts a second chance
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
No Proof That 'Doping' With EPO Gives Athletes an Edge: Review
(Date:5/31/2016)... ... May 31, 2016 , ... CallTrackingMetrics's software gives ... monitor the performance of sales and support staff, and to efficiently route calls ... allows customers to record, transcribe, route, document, and report on everything going on ...
(Date:5/31/2016)... ... ... The Global Wellness Summit (GWS), an annual conference for international leaders ... spa and beauty in Europe. The organization asked its partner experts in Europe - ... - to forecast where wellness is headed in Europe. Predictions range from European nations ...
(Date:5/31/2016)... ... 2016 , ... Interest is on the rise for using the CRISPR-Cas9 system ... for RNAi hit validation. A key reason may be that high-throughput synthesis—combined with a ... RNA (crRNA) collections in arrayed formats. , Arrayed crRNA screens have ...
(Date:5/31/2016)... ... ... Dr. Charles A. Ditta attained his Doctor of Medical Dentistry Degree from ... where he graduated in the top ten percentile of his class. Dr. Ditta has ... has been a member in good standing for thirty years in the American Dental ...
(Date:5/30/2016)... (PRWEB) , ... May 30, 2016 , ... As the ... for their children and their efforts to keep their households lice free. , ... Hawaii are enacting new policies that keep kids in the classroom despite the fact ...
Breaking Medicine News(10 mins):
(Date:5/31/2016)... May 31, 2016  Diplomat Pharmacy, Inc. (NYSE: ... that Phil Hagerman , Chairman & CEO, and ... Blair 36 th Annual Growth Stock Conference in ... Mr. Whelan are scheduled to present at the conference on ... live audio-only webcast of the presentation and related presentation materials ...
(Date:5/31/2016)... , May 31, 2016 ... and Annotate Content From Elsevier,s ScienceDirect Database ... scientific, technical and medical information products and services, ... Berlin -based scientific collaboration platform PaperHive to enable ... over 12 million articles on ScienceDirect , ...
(Date:5/31/2016)... PUNE, India , May 31, 2016 ... 2016" market research report with comparative analysis of Asthma ... mechanism of action (MoA), route of administration (RoA) and ... and press releases. It also reviews key players involved ... on late-stage and discontinued projects. Complete report ...
Breaking Medicine Technology: